Tarceva and Capecitabine for Pancreatic Cancer
Clinical trial NCT00125021 · COMPLETED
Trial details
- NCT number
- NCT00125021
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2004-06-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.